导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -9.55% | 817/1050 |
| 近一周 | -3.33% | 863/1104 |
| 近一月 | -6.25% | 750/1102 |
| 近一季 | -10.81% | 699/1092 |
| 近半年 | -17.96% | 953/1070 |
| 近一年 | -5.11% | 654/1018 |
| 近两年 | 7.69% | 849/926 |
| 近三年 | -19.30% | 770/834 |
| 成立以来 | -27.83% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
2.24% 322/1070 |
0.23% 693/1101 |
- - |
- - |
| 2025 | 12.86% 788/1065 |
-5.30% 991/1014 |
-5.56% 969/1038 |
28.58% 382/1050 |
-1.85% 548/1065 |
| 2024 | -15.81% 874/1011 |
-5.98% 612/960 |
-19.04% 953/983 |
31.04% 4/991 |
-15.60% 981/1011 |
| 2023 | -40.98% 844/952 |
-8.79% 846/880 |
-5.11% 529/895 |
-25.58% 888/915 |
-8.37% 786/952 |
| 2022 | -23.00% 436/867 |
-17.28% 382/773 |
6.67% 426/806 |
-6.43% 94/845 |
-6.73% 692/867 |
| 2021 | 25.64% 109/740 |
7.25% 27/580 |
1.23% 529/659 |
9.39% 75/704 |
5.78% 192/740 |
| 2020 | - - |
- - |
- - |
- - |
19.40% 129/554 |
| 2019 | - - |
- - |
- - |
- - |
- - |
| 2018 | - - |
- - |
- - |
- - |
- - |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商前沿医疗保健股票C | 0.8165 | 53.69% |
| 招商医药健康产业股票 | 2.6450 | 48.73% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 嘉实医疗保健股票 | 2.6190 | 39.05% |
| 广发医药精选股票C | 1.3103 | 38.32% |
| 前海开源公共卫生股票C | 0.4647 | 37.30% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 交银医药创新股票C | 3.0948 | 35.86% |
| 广发高端制造股票C VS. 东吴新产业精选股票A(580008) |